drugset
Drugs / Dl-Alpha Tocopheryl Acetate
last change Aug 2021 re-read 2 minutes ago

Dl-Alpha Tocopheryl Acetate

Investigated by
Oregon State University · Shriners Hospitals for Children · University of Texas

Trials 1 · a red edge is where a trial was stopped

today NCT01413620 · Ph 1
2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01413620 Aug 2011 → Aug 2017 — Shriners Hospitals for Children Withdrawn No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02620345 Background Jan 2010 → Oct 2015 benign neoplasm of corpus uteri Trieu, Nguyen Thi, M.D. Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as dl-alpha-tocopheryl acetate “Cholecalciferol 400 IU/day Dl-Alpha Tocopheryl Acetate 11IU Thiamin Mononitrate 1.5 mg/day” NCT02620345 ↗
1

NCT01413620 ↗
Action Restore “restore levels of vitamin E in adipose tissue” NCT01413620 ↗
Route Oral “The dose of aqueous vitamin E (Aqueous Vitamin E Oral Drops, Silarx, No. 54838-0005-30, Spring Valley, NY) will be given orally.” NCT01413620 ↗